Back to today’s briefing

Story perspectives

FDA Approves Game-Changing Herpes Virus for Melanoma Treatment

7/9/2025

33 8

Summary

Story summary

The FDA is set to make a pivotal decision on Replimune's RP1, a groundbreaking modified herpes virus aimed at combating advanced melanoma. In trials, a remarkable one-third of patients saw significant tumor shrinkage, with some even achieving complete regression. This innovative treatment could offer hope for those battling melanoma that resists current therapies.

1 of 1

Story summary

The FDA is set to make a pivotal decision on Replimune's RP1, a groundbreaking modified herpes virus aimed at combating advanced melanoma. In trials, a remarkable one-third of patients saw significant tumor shrinkage, with some even achieving complete regression. This innovative treatment could offer hope for those battling melanoma that resists current therapies.